about
Control of Cross Talk between Angiogenesis and Inflammation by Mesenchymal Stem Cells for the Treatment of Ocular Surface DiseasesSystemic Immunosuppression in High-Risk Penetrating Keratoplasty: A Systematic ReviewIslet inflammation in plain sightEffector and Regulatory T Cell Trafficking in Corneal Allograft RejectionPresurgical corticosteroid treatment improves corneal transplant survival in miceEffect of sorafenib in a murine high risk penetrating keratoplasty modelVascular Endothelial Growth Factor Receptor 1 morpholino increases graft survival in a murine penetrating keratoplasty model.IFN-γ blocks CD4+CD25+ Tregs and abolishes immune privilege of minor histocompatibility mismatched corneal allografts.IL-17A-dependent CD4+CD25+ regulatory T cells promote immune privilege of corneal allograftsAdipose-derived mesenchymal stem cell administration does not improve corneal graft survival outcome.Cortisol biosynthesis in the human ocular surface innate immune response.Comparison of galectin expression signatures in rejected and accepted murine corneal allografts.Total protein concentration and T-cell suppression activity of aqueous humour before and after penetrating keratoplastyArginine depletion as a mechanism for the immune privilege of corneal allografts.The role of atopy in corneal graft survival in keratoconusPharmacotherapy of corneal transplantation.Ethical and regulatory guidelines in clinical trials of xenocorneal transplantation in Korea; the Korean xenocorneal transplantation consensus statement.The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of xenocorneal transplantation.Progress in Corneal Stromal Repair: From Tissue Grafts and Biomaterials to Modular Supramolecular Tissue-Like Assemblies.Mucosal immune tolerance at the ocular surface in health and disease.New insights into mononuclear phagocyte biology from the visual system.Low oxygen tension and macromolecular crowding accelerate extracellular matrix deposition in human corneal fibroblast culture.Dental pulp stem cells: a new cellular resource for corneal stromal regeneration.Mesenchymal stem cells: Potential role in corneal wound repair and transplantation.Potential lymphangiogenesis therapies: Learning from current antiangiogenesis therapies-A review.Initial study of α1,3-galactosyltransferase gene-knockout/CD46 pig full-thickness corneal xenografts in rhesus monkeys.[Old immune system- new information? Importance of mononuclear phagocytes in corneal allograft rejection].Expression of Lymphangiogenic Markers in Rejected Human Corneal Buttons after Penetrating Keratoplasty.Mesenchymal stem cell therapy promotes corneal allograft survival in rats by local and systemic immunomodulation.Activation of human macrophages by human corneal allogen in vitro.Lectin-Glycan Interactions in Corneal Infection and InflammationThe effects of donor age on organ transplants: A review and implications for aging research
P2860
Q26750660-96582F58-9E64-480A-962C-F9D38443ED52Q26764905-11C76A0E-38D0-4181-8FB5-7A8CD3215637Q27012796-8EFDECAD-F11C-4D1E-86D5-2DD932BF450AQ33678965-0BD26E22-177F-4B8F-9466-966F8F5F66BBQ33861559-9A297474-2136-4F29-B1B5-BA1827EABF67Q33914667-05E953E9-17FA-4BA2-9FF9-E704A5C71180Q33961186-8F3AF08D-8692-4EDB-83CA-0CC8ED56E4ABQ33970941-2A18D969-C613-4AE9-A6E6-415FEB76579FQ35032693-BD8E89E7-D4A2-4650-8D53-AD5DAAC23616Q35137384-1AC48BE8-EC6F-4E9D-B3B8-0209F7F12E79Q35149219-8774C925-5325-4029-AB4E-44A2677DEADCQ35602405-62CFD4FC-743F-4E5D-ADAD-15C9C9971A1CQ35676275-83027EDE-2018-4B96-8C4D-F8FD8BDBBF25Q36043930-4449F200-8FD6-456A-99C1-316AF5CD7AE7Q36352936-D6A5D6DA-0A65-4E92-9F29-00CF84F9A9D5Q37994335-79BCC82C-20C5-421D-BE80-8DDB1127B6DEQ38107548-F2ED19D2-03A7-4008-944E-9C45FF95F355Q38245175-BFD808C0-808E-4B0C-9F3F-EC231452D43CQ38888357-4DA1A0B9-A04F-47BE-A4BF-FB5C53280134Q39097223-90606FF8-AD90-4567-B99B-BBDF58E327E6Q39202010-1724A497-4D5C-4A0B-90CF-B8C427D284BCQ39425106-EBC1003F-B040-4620-A18A-C2F1CE6B78ADQ41874569-4167463B-2830-47DF-9FF1-F7D1C71883D8Q41982803-088DE1E9-2AAB-42E5-9B05-49C97B0CBAD3Q50419857-361A9526-D379-4C9D-ADF1-4CCE5948572DQ51216604-1AD03C95-6191-43A0-940E-26929D1F59BEQ53172787-97C31EC4-3314-4A24-A7D2-777376018FA5Q54187943-F4AB586C-6A20-41BB-86AB-2551D049A6E6Q54188853-754EE078-7FCF-4AD7-BA2A-C119CE64A752Q54915310-30017311-00A0-4045-88C1-39D812E00DC9Q57817455-26C0A487-0201-408D-8F96-E63808B31309Q58776430-06B403BD-454A-4FBB-80E4-10CB25960F95
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immune privilege of corneal allografts.
@en
Immune privilege of corneal allografts.
@nl
type
label
Immune privilege of corneal allografts.
@en
Immune privilege of corneal allografts.
@nl
prefLabel
Immune privilege of corneal allografts.
@en
Immune privilege of corneal allografts.
@nl
P2860
P1476
Immune privilege of corneal allografts.
@en
P2093
D Frank P Larkin
Jerry Y Niederkorn
P2860
P304
P356
10.3109/09273948.2010.486100
P577
2010-06-01T00:00:00Z